Investors & Media

Developing non-viral gene transfer-based cell therapies to effectively access and treat the millions of people diagnosed globally each year with solid tumors by weaponizing the body’s immune system. Leveraging its multi-platform approach, Alaunos is at the forefront of immuno-oncology.